SANDIMMUN ciclosporin 250mg/5mL injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

sandimmun ciclosporin 250mg/5ml injection ampoule

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 50 mg/ml - injection, concentrated - excipient ingredients: peg-35 castor oil; ethanol - this product is accepted for registration as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 16 june 1992 from dr l. hunt. indications: as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. extended indications as at 15 october 1993: for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired . indications as at 11 february 1994 from dr j mcginness: 1. as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. 2. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasi